期刊文献+

ShineRoar探针技术检测单核苷酸多态性 被引量:8

A novel method for detecting single-nucleotide polymorphisms by using ShineRoar probes
原文传递
导出
摘要 目的建立一种低成本、高效率、操作简便的单核苷酸多态性(SNP)检测技术。方法采用自行设计的"ShineRoar 探针",结合融解曲线技术检测目的基因 SNP。并根据其工作原理分别对肿瘤坏死因子受体Ⅱ(TNFRⅡ)和载脂蛋白 M(apoM)的基因多态性进行检测;同时用 DNA 测序技术鉴定 ShineRoar 探针技术的准确性。结果融解曲线分析结果显示,某一基因的野生型及突变型纯合子分别在2个不同的融解温度出现融解谷。TNFRⅡ基因第6外显子196位突变(ATG→AGG)所产生的 T 和 G 等位基因的融解温度分别为(52.84±0.75)℃和(58.38±0.61)℃;apoM T-778C 突变所产生的 T 和 C 等位基因的融解温度分别为(42.55±0.73)℃和(49.19±0.57)℃。一致性 Kappa 检验显示 ShineRoar 探针技术与 DNA 测序技术的 SNP 检测结果一致(Kappa=1,P=0.000)。结论ShineRoar 探针技术简单、快速、准确,适用于大批量基因分型的研究。 Objective The present study demonstrates a novel, simple and cost-effective method for detecting known SNP genotyping by using ShineRoar probes. Methods The SNP of target genes detected by using the ShineRoar probes and melting curve analysis. Tumor necrosis factor receptor Ⅱ (TNFRⅡ) and apolipoprotein M (apoM) had been employed as target genes to describe the method in details. The PCR products of TNFR n and apoM were collected and sequenced. Results The melting temperatures ( TM ) were significantly different between mutated genotypes and wild-type genotype. A biallelic SNP marker (T/ G) at position 196 in exon 6 of TNFR n gene showed two melting valleys with the appropriate TMs at (52.84±0.75) ℃ and (58.38 ±0.61) ℃respectively. For apoM T-778C, TMs of homozygous T genotype and C genotype were (42.55 ± 0.73 ) ℃ and (49.19 ± 0.57 ) ℃ , respectively. Moreover, this genotyping method was validated by the DNA sequence analyses ( Kappa = 1, P = 0.000 ). Conclusion It is concluded that this novel method is simple and economical and it is suitable for a large-scale genotyping screening.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2007年第6期609-612,共4页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金(30570752) 常州市831工程资助项目(200602) 常州市卫生局资助项目(047182)
关键词 多态性 单核苷酸 基因型 受体 肿瘤坏死因子 Ⅱ型 载脂蛋白类 Single nucleotide polymorphism Genotype Receptor, tumor necrosis factor, type Ⅱ Apolipoproteins
  • 相关文献

参考文献20

  • 1Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res, 1998,8 : 1229-1231.
  • 2Carlson CS, Newman TL, Nickerson DA. SNPing in the human genome. Curr Opin Chem Biol, 2001,5:78-85.
  • 3Ergen E, Weber M, Jacob J, et al. Twin probes as a novel tool for the detection of single-nucleotide polymorphisms. Chemistry, 2006,12:3707-3713.
  • 4Beltinger CP, White PS, Maris JM, et al. Physical mapping and genomic structure of the human TNFR2 gene. Genomics, 1996, 35:94-100.
  • 5Komata T, Tsuchiya N,. Matsushita M, et al. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens, 1999,53:527-533.
  • 6Barton A, John S, Oilier WE, et al. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor Ⅱ, but not tumor necrosis factor receptor Ⅰ, in Caucasians. Arthritis Rheum, 2001,44:61-65.
  • 7Xu N, Dahlback B. A novel human apolipoprotein ( apoM ). J Biol Chem, 1999, 274:31286-31290.
  • 8Luo G, Zhang X, Nilsson-Ehle P, et al. Apolipoprotein M. Lipids Health Dis, 2004,3:21.
  • 9Niu N, Zhu X, Liu Y, et al. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese. Diabetes Metab Res Rev, 2007,23:21-25.
  • 10Botstein D, White RL, Skolnick M, et al. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum C, enet, 1980,32:314-331.

同被引文献70

  • 1Sankar VH, Girisha KM, Gilmour A, et al. TNFR2 gene polymorphism in coronary artery disease. Indian J Med Sci,2005, 59 : 104-108.
  • 2Allen RA, Lee EM, Roberts DH, et al. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest,2001,31:843-851.
  • 3Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med, 1999,340 : 115-126.
  • 4Woods A, Brull DJ, Humphries SE, et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J,2000,21 : 1574-1583.
  • 5Andreotti F, Porto I, Crea F, et al. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart,2002,87:107-112.
  • 6Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [ Health ABC ~ Study ). Am J Cardi, 2003,92 : 522- 528.
  • 7Barath P, Fishbein MC, Cao J, et al. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol, 1990, 65:297-302.
  • 8Vaddi K, Nicolini FA, Mehta P, et al. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation, 1994,90:694-699.
  • 9Santee SM, Owen-Schaub LB. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem, 1996,271:21151-21159.
  • 10Komata T, Tsuchiya N, Matsushita M, et al. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens, 1999,53:527-533.

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部